Nugent v. Rogosin Institute

105 F. Supp. 2d 106, 2000 U.S. Dist. LEXIS 10538, 2000 WL 1023466
CourtDistrict Court, E.D. New York
DecidedJuly 6, 2000
Docket1:98-cv-07192
StatusPublished
Cited by3 cases

This text of 105 F. Supp. 2d 106 (Nugent v. Rogosin Institute) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nugent v. Rogosin Institute, 105 F. Supp. 2d 106, 2000 U.S. Dist. LEXIS 10538, 2000 WL 1023466 (E.D.N.Y. 2000).

Opinion

MEMORANDUM AND ORDER

TRAGER, District Judge.

Defendant Rogosin Institute, Inc. (“Ro-gosin”) has moved for summary judgment against plaintiff Peggy Nugent (“Nugent”). Nugent sued Rogosin, her former employer, for terminating her employment in violation of the Americans with Disabilities Act (“ADA”), 42 U.S.C. §§ 1201 et seq., the New York State Human Rights Law (“NYSHRL”), N.Y. Exec. Law § 296 et seq., and the New York City Administrative Code § 8-107(l)(a) (“NYCAC”). Nu-gent claims that the chemicals used in her work environment caused her to develop allergic asthma, which eventually led to the illegal termination of her employment.

Background

(1)

Rogosin is “a private not-for-profit medical research and health center” that operates the Rogosin Kidney Center (“RKC”) in Manhattan. See Def.’s Statement Pursuant to Local Civ. R. 56.1(a) ¶ A.1 [hereinafter Def.’s 56.1]. Patients come to RKC to receive kidney dialysis treatment, a process by which toxins are cleansed from the patients’ blood. See id ¶ A.3.

Nugent began working for Rogosin as an assistant head nurse at RKC in March of 1992. See Declaration of Lisa E. Cleary dated Feb. 25, 2000 [hereinafter Cleary Decl.], Ex. A at 13 (Dep. of Peggy Nugent) [hereinafter Nugent Dep.]. Her duties as assistant head nurse included direct patient care and consultation with physicians, as well as administrative tasks, such as staff scheduling and management meetings. See id. at 15-16. According to her first, sixty-day evaluation, Nugent’s performance as an assistant head nurse “Exceeded] Standards” in every category. See Cleary Deck, Ex. E (“Progress Report on New Employee” dated June 24, 1992). In fact, only five months after she started working at RKC, she was approached Administrator Joanne McDarby (“McDarby”) about an available head nurse position. See Nugent Dep. at 20. This promotion was officially offered to Nugent during a lunch meeting attended by McDarby, Dr. John Sullivan (“Dr. Sullivan”), RKC’s Medical Director, and Larry Maglione (“Maglione”), RKC’s Chief Financial Officer. See id. at 21.

Nugent accepted the promotion and was designated Head Nurse of RKC in February of 1993. See Nugent Dep. at 24-25, *108 186. She testified that her responsibilities “changed greatly” after she was promoted to Head Nurse. See id. at 21. Although she continued to spend at least one or two hours a day in the dialysis unit making rounds with the charge nurse, talking with patients and doctors, and visiting the resident social workers and dieticians, see id. at 22-23, most of her daily tasks were “much more managerial” and administrative, see id. at 21. According to her own testimony, however, visiting the dialysis unit remained an essential component of her job. See id. at 117,124-25.

From early 1993 until the summer of 1996, Nugent’s performance evaluations reflected that she was satisfactorily executing her duties as Head Nurse, and handwritten comments made by McDarby and Nugent herself reveal that everyone was happy with Nugent’s employment at RKC. See, e.g., Cleary Deck, Ex. E (“Annual Management Performance Review” (“AMPR”) dated June 1993); id. (AMPR dated June 1994); id. (AMPR dated June 1995). Nugent characterized her working relationship with Dr. Sullivan as “excellent” throughout her tenure at RKC and her working relationship -with McDarby as “very, very good,” until the summer of 1996, when an incident unrelated to this case put a strain on their friendly working relationship. See Nugent Dep. at 26. 1

(2)

At RKC, the filter used during a patient’s dialysis (a “dialyzer”) is flushed with saline and transported to the “reuse room” as soon as the treatment is finished. See Cleary Deck, Ex. B at 10 (Dep. of Dr. John F. Sullivan) [hereinafter Sullivan Dep.]. The structural integrity of each filter is then checked, and if sound, the filter is “filled with a sterilant called glutaral-dehyde” and stored until the patient’s next treatment. Id. The same filter will continue to be used by the same patient until it is damaged or has been used thirty times. See id.

When Nugent was promoted to Head Nurse in February of 1993, she was given an office located near the reuse room. Nugent’s office was an L-shaped room, measuring approximately six feet by seventeen feet. See Sullivan Dep. at 28; see also Cleary Deck, Ex. C (blueprints of the second floor of RKC). The door to her office was about five feet away from the reuse room door, and her desk was about twenty to twenty-five feet away from the reuse room door. See Sullivan Dep. at 17. Although discovery lasted approximately nine months, Nugent has not produced any evidence regarding the ventilation of the reuse room, except her own statement that a co-worker told her “everything was properly ventilated” and that RKC had “never been cited” by any regulatory agency. Nugent Dep. at 96. Nugent also stated that the door to the reuse room was generally shut, but “[i]t wasn’t closed tightly.” Nugent Dep. at 97. RKC has used glutar-aldehyde in its reuse room throughout the entire term of Nugent’s employment. See Def.’s 56.1, ¶ B.13.

*109 (3)

In the fall of 1996, Nugent suddenly began experiencing breathing problems while at work. According to Nugent, an hour after she arrived at work on Friday, October 18th, she began to lose her voice, feel short of breath, and have chest tightness. See Nugent Dep. at 75. She was able to complete that work day, but couldn’t get out of bed all weekend. See id. at 76. By Monday morning (October 21), Nugent was still experiencing “very, very bad shortness of breath,” so she called into work sick and went to see Dr. Tarantela. See id.

Dr. Tarantela ordered blood work, a chest x-ray, and a pulmonary function test, all of which were within normal limits. See Supplemental Decl. of Lisa E. Cleary dated Apr. 28, 2000 (“Cleary Suppl. Decl.”), Ex. I (Letter from Dr. Tarantela of 4/15/97) [hereinafter Tarantela Ltr.]. Dr. Tarantela explained to Nugent that she was suffering from a bronchial inflammation, and he questioned her about the chemicals used in her work environment in an attempt to determine if “the irritants in the reuse room [] caused this reaction.” See Nugent Dep. at 77-78. Dr. Tarantela also prescribed a variety of bronchial inhalers for Nugent’s daily use. See Taran-tola Ltr. Nugent did not return to work at all that week (October 21st-25th), as she continued to feel very short of breath. See Nugent Dep. at 79; Cleary Deck, Ex. F (1996 attendance record).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Witt v. Bristol Farms
S.D. California, 2021
Gomez v. Laidlaw Transit, Inc.
455 F. Supp. 2d 81 (D. Connecticut, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
105 F. Supp. 2d 106, 2000 U.S. Dist. LEXIS 10538, 2000 WL 1023466, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nugent-v-rogosin-institute-nyed-2000.